| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | President And CEO
3 companies
Paul Steven M is a President And CEO at Voyager Therapeutics, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 4 buys and 12 sells.
Estimated insider holdings value: $5.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 12, 2025 | RAPP Rapport Therapeutics, Inc. | Director | Buy | 41,666 | $24.65 | $1,027,111.28 | +147.3% | +21.1% | - | |
| Apr 1, 2022 | ALNY Alnylam Pharmaceuticals, Inc. | Director | Sale+OE | 15,000 | $170.69 | $2,560,370.82 | -23.2% | -13.8% | +18.3% | |
| Dec 18, 2020 | ALNY Alnylam Pharmaceuticals, Inc. | Director | Sale+OE | 15,000 | $140.00 | $2,100,000.00 | -93.8% | - | - | |
| Feb 10, 2020 | ALNY Alnylam Pharmaceuticals, Inc. | Director | Sale+OE | 30,000 | $130.00 | $3,900,000.00 | -96.8% | - | - | |
| Jan 14, 2016 | VYGR Voyager Therapeutics, Inc. | President And CEO | Buy | 10,000 | $14.07 | $140,690.00 | +1.2% | - | - | |
| Jan 26, 2015 | ALNY Alnylam Pharmaceuticals, Inc. | Director | Buy | 1,000 | $95.00 | $95,000.00 | New | - | - |